Autoimmune hepatitis: current challenges and future prospects

References

• CowlingDCMackayIRTaftLILupoid hepatitisLancet195627169571323132613386250
   PubMed Web of Science ®Google Scholar
• GregorioGVPortmannBReidFAutoimmune hepatitis in childhood: a 20-year experienceHepatology19972535415479049195
   PubMed Web of Science ®Google Scholar
• NewtonJLBurtADParkJBMathewJBassendineMFJamesOFAutoimmune hepatitis in older patientsAge Ageing19972664414449466294
   PubMed Web of Science ®Google Scholar
• OmagariKKinoshitaHKatoYClinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, JapanJ Gastroenterol199934222122610213122
   PubMed Web of Science ®Google Scholar
• GregorioGVMcFarlaneBBrackenPVerganiDMieli-VerganiGOrgan and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver diseaseAutoimmunity200235851551912765477
   PubMed Web of Science ®Google Scholar
• MuratoriPLalanneCFabbriACassaniFLenziMMuratoriLType 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotypeAliment Pharmacol Ther201541121281128725898847
   PubMed Web of Science ®Google Scholar
• UmemuraTOtaMGenetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitisClin J Gastroenterol20158636036626661115
   PubMedGoogle Scholar
• HeneghanMAYeomanADVermaSSmithADLonghiMSAutoimmune hepatitisLancet201338299021433144423768844
   PubMed Web of Science ®Google Scholar
• AlvarezFBergPABianchiFBInternational Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJ Hepatol19993192993810580593
   PubMed Web of Science ®Google Scholar
• ChazouillèresOWendumDSerfatyLMontembaultSRosmorducOPouponRPrimary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapyHepatology19982822963019695990
   PubMed Web of Science ®Google Scholar
• TiniakosDGBrainJGBuryYARole of histopathology in autoimmune hepatitisDig Dis201533suppl 2536426642062
   PubMed Web of Science ®Google Scholar
• HeneghanMAMcFarlaneIGCurrent and novel immunosuppressive therapy for autoimmune hepatitisHepatology200235171311786954
   PubMed Web of Science ®Google Scholar
• ZachouKGatselisNKArvanitiPA real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitisAliment Pharmacol Ther201643101035104726991238
   PubMed Web of Science ®Google Scholar
• DonaldsonPTImmunogenetics in liver diseaseBaillieres Clin Gastroenterol19961035335498905122
   PubMed Web of Science ®Google Scholar
• SekiTKiyosawaKInokoHOtaMAssociation of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patientsHepatology1990126130013042175292
   PubMed Web of Science ®Google Scholar
• Eskandari-NasabETahmasebiAHashemiMMeta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitisImmunol Invest201544433134825942345
   PubMed Web of Science ®Google Scholar
• WebbGJHirschfieldGMUsing GWAS to identify genetic predisposition in hepatic autoimmunityJ Autoimmun201666253926347073
   PubMed Web of Science ®Google Scholar
• BittencourtPLGoldbergACCançadoELGenetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2Am J Gastroenterol19999471906191310406258
   PubMed Web of Science ®Google Scholar
• JungeNTiedauMVerboomMHuman leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosisEur J Pediatr2016175452753726567543
   PubMed Web of Science ®Google Scholar
• HassanNSiddiquiARAbbasZClinical profile and HLA typing of autoimmune hepatitis from PakistanHepat Mon20131312e1359824358040
   PubMed Web of Science ®Google Scholar
• UmemuraTKatsuyamaYYoshizawaKHuman leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in JapanPLoS One201496e10056524956105
   PubMed Web of Science ®Google Scholar
• FurumotoYAsanoTSugitaTEvaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitisBMC Gastroenterol20151514426489422
   PubMed Web of Science ®Google Scholar
• van GervenNMde BoerYSZwiersADutch Autoimmune Hepatitis Study GroupHLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1Genes Immun201516424725225611558
   PubMed Web of Science ®Google Scholar
• Djilali-SaiahIFakhfakhALouafiHCaillat-ZucmanSDebrayDAlvarezFHLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitisJ Hepatol200645684485017050030
   PubMed Web of Science ®Google Scholar
• YangFWangQBianZRenLLJiaJMaXAutoimmune hepatitis: east meets westJ Gastroenterol Hepatol20153081230123625765710
   PubMed Web of Science ®Google Scholar
• BuxbaumJQianPAllenPMPetersMGHepatitis resulting from liver-specific expression and recognition of self-antigenJ Autoimmun200831320821518513923
   PubMed Web of Science ®Google Scholar
• LonghiMSMaYMieli-VerganiGVerganiDAetiopathogenesis of autoimmune hepatitisJ Autoimmun201034171419766456
   PubMed Web of Science ®Google Scholar
• ZierdenMKühnenEOdenthalMDienesHPEffects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitisGastroenterology2010139397598620639127
   PubMed Web of Science ®Google Scholar
• PeiselerMSebodeMFrankeBFOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequencyJ Hepatol201257112513222425700
   PubMed Web of Science ®Google Scholar
• GrantCRLiberalRHolderBSDysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitisHepatology20145931007101523787765
   PubMed Web of Science ®Google Scholar
• WadaYSatoCTomitaKPossible autoimmune hepatitis induced after chronic active Epstein-Barr virus infectionClin J Gastroenterol201471586126183510
   PubMedGoogle Scholar
• ChibaTGotoSYokosukaOFatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitisEur J Gastroenterol Hepatol200416222522815075999
   PubMed Web of Science ®Google Scholar
• YamashitaHShimizuATsuchiyaHChronic active Epstein-Barr virus infection mimicking autoimmune hepatitis exacerbation in a patient with systemic lupus erythematosusLupus201423883383624608961
   PubMed Web of Science ®Google Scholar
• BonderARetanaAWinstonDMLeungJKaplanMMPrevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndromeClin Gastroenterol Hepatol20119760961221440668
   PubMed Web of Science ®Google Scholar
• DienesHPErberichHDriesVSchirmacherPLohseAAutoimmune hepatitis and overlap syndromesClin Liver Dis20026234936212122860
   PubMedGoogle Scholar
• ChouMJLeeSLChenTYTsayGJSpecificity of antinuclear antibodies in primary biliary cirrhosisAnn Rheum Dis19955421481517702406
   PubMed Web of Science ®Google Scholar
• KobayashiMKakudaYHaradaKClinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitisWorld J Gastroenterol201420133597360824707143
   PubMed Web of Science ®Google Scholar
• KuiperEMZondervanPEvan BuurenHRParis criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndromeClin Gastroenterol Hepatol20108653053420304098
   PubMed Web of Science ®Google Scholar
• ZhangHLiSYangJA meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinationsPrz Gastroenterol201510314815526516380
   PubMedGoogle Scholar
• OzaslanEEfeCHeurgué-BerlotAFactors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitisClin Gastroenterol Hepatol201412586386924076417
   PubMed Web of Science ®Google Scholar
• van BuurenHRvan HoogstratenHJETerkivatanTSchalmSWVleggaarFPHigh prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitisJ Hepatol200033454354811059858
   PubMed Web of Science ®Google Scholar
• TencaAFärkkiläMArolaJJaakkolaTPenaginiRKolhoKLClinical course and prognosis of pediatric-onset primary sclerosing cholangitisUnited European Gastroenterol J201644562569
   Web of Science ®Google Scholar
• VerdonkRCLozanoMFvan den BergAPGouwASBile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitisLiver Int20163691362136926849025
   PubMed Web of Science ®Google Scholar
• BjörnssonETalwalkarJTreeprasertsukSDrug-induced autoimmune hepatitis: clinical characteristics and prognosisHepatology20105162040204820512992
   PubMed Web of Science ®Google Scholar
• AllaVAbrahamJSiddiquiJAutoimmune hepatitis triggered by statinsJ Clin Gastroenterol200640875776116940892
   PubMed Web of Science ®Google Scholar
• SuzukiABruntEMKleinerDEThe use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryHepatology201154393193921674554
   PubMed Web of Science ®Google Scholar
• LicataAMaidaMCabibiDClinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort studyDig Liver Dis201446121116112025224696
   PubMedGoogle Scholar
• YeongTTLimKHGoubetSParnellNVermaSNatural history and outcomes in drug-induced autoimmune hepatitisHepatol Res2016463E79E8825943838
   PubMed Web of Science ®Google Scholar
• de BoerYSKosinskiASUrbanTJDrug-Induced Liver Injury Network. Features of autoimmune hepatitis in patients with drug-induced liver injuryClin Gastroenterol Hepatol Epub2016614
   Web of Science ®Google Scholar
• BeaunePHLecoeurSImmunotoxicology of the liver: adverse reactions to drugsJ Hepatol199726suppl 23742
   Web of Science ®Google Scholar
• De Luca-JohnsonJWangensteenKJHansonJKrawittEWilcoxRNatural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver diseaseDig Dis Sci20166192710272027262844
   PubMed Web of Science ®Google Scholar
• MüllerPMessmerMBayerMPfeilschifterJMHintermannEChristenUNon-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse modelJ Autoimmun201669515826924542
   PubMed Web of Science ®Google Scholar
• LoriaPLonardoALeonardiFNon-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlatesDig Dis Sci200348112173218114705824
   PubMed Web of Science ®Google Scholar
• HuKQYangHLinYCLindsayKLRedekerAGClinical profiles of chronic hepatitis C in a major county medical center outpatient setting in United StatesInt J Med Sci2004129210015912201
   PubMedGoogle Scholar
• MaYPeakmanMLobo-YeoADifferences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infectionClin Exp Immunol199497194998033426
   PubMed Web of Science ®Google Scholar
• KammerARvan der BurgSHGrabscheidBMolecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognitionJ Exp Med1999190216917610432280
   PubMed Web of Science ®Google Scholar
• EfeCWahlinSOzaslanEDiagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/CScand J Gastroenterol201348450450823448312
   PubMed Web of Science ®Google Scholar
• PrattDSFawazKARabsonADellelisRKaplanMMA novel histological lesion in glucocorticoid-responsive chronic hepatitisGastroenterology19971136646689247489
   PubMed Web of Science ®Google Scholar
• MiyakeYIwasakiYTeradaRClinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosisHepatol Res2007371080180517559422
   PubMed Web of Science ®Google Scholar
• ZenYNotsumataKTanakaNNakanumaYHepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis?Hum Pathol200738111669167517669466
   PubMed Web of Science ®Google Scholar
• HoferHOesterreicherCWrbaFFerenciPPennerECentrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentationJ Clin Pathol200659324624916505273
   PubMed Web of Science ®Google Scholar
• SinghRNairSFarrGMasonAPerrilloRAcute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literatureAm J Gastroenterol200297102670267312385459
   PubMed Web of Science ®Google Scholar
• AizawaYAbeHSugitaTCentrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitisEur J Gastroenterol Hepatol201628439139726657454
   PubMed Web of Science ®Google Scholar
• StravitzRTLefkowitchJHFontanaRJAcute Liver Failure Study GroupAutoimmune acute liver failure: proposed clinical and histological criteriaHepatology201153251752621274872
   PubMed Web of Science ®Google Scholar
• FeldJJDinhHArenovichTMarcusVAWanlessIRHeathcoteEJAutoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcomeHepatology2005421536215954109
   PubMed Web of Science ®Google Scholar
• CzajaAJFeatures and consequences of untreated type 1 autoimmune hepatitisLiver Int200929681682319018980
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL clinical practice guidelines: autoimmune hepatitisJ Hepatol2015634971100426341719
   PubMed Web of Science ®Google Scholar
• LamersMMvan OijenMGPronkMDrenthJPTreatment options for autoimmune hepatitis: a systematic review of randomized controlled trialsJ Hepatol201053119119820400196
   PubMed Web of Science ®Google Scholar
• MannsMPCzajaAJGorhamJDAmerican Association for the Study of Liver DiseasesDiagnosis and management of autoimmune hepatitisHepatology20105162193221320513004
   PubMed Web of Science ®Google Scholar
• KrynetskiEYTaiHLYatesCRGenetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsPharmacogenetics1996642792908873214
   PubMedGoogle Scholar
• TakahashiAOhiraHAbeKIntractable Liver and Biliary Diseases Study Group of Japan. Rapid corticosteroid tapering: important risk factor for type 1 autoimmune hepatitis relapse in JapanHepatol Res201545663864425070037
   PubMed Web of Science ®Google Scholar
• YoshizawaKMatsumotoAIchijoTLong-term outcome of Japanese patients with type 1 autoimmune hepatitisHepatology201256266867622334246
   PubMed Web of Science ®Google Scholar
• ShermanKENarkewiczMPintoPCCyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitisJ Hepatol1994216104010477699225
   PubMed Web of Science ®Google Scholar
• AqelBAMachicaoVRosserBSatyanarayanaRHarnoisDMDicksonRCEfficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitisJ Clin Gastroenterol200438980580915365410
   PubMed Web of Science ®Google Scholar
• CzajaAJLindorKDFailure of budesonide in a pilot study of treatment-dependent autoimmune hepatitisGastroenterology200011951312131611054389
   PubMed Web of Science ®Google Scholar
• DanielssonAPrytzHOral budesonide for treatment of autoimmune chronic active hepatitisAliment Pharmacol Ther1994865855907696446
   PubMed Web of Science ®Google Scholar
• CzajaAJCarpenterHALindorKDUrsodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trialHepatology19993061381138610573515
   PubMed Web of Science ®Google Scholar
• MiyakeYIwasakiYKobashiHEfficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitisHepatol Int20093455656219847577
   PubMed Web of Science ®Google Scholar
• ZachouKGatselisNPapadamouGRigopoulouEIDalekosGNMycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patientsJ Hepatol201155363664621238519
   PubMed Web of Science ®Google Scholar
• HlivkoJTShiffmanMLStravitzRTA single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitisClin Gastroenterol Hepatol2008691036104018586559
   PubMed Web of Science ®Google Scholar
• YeomanADWestbrookRHZenYPrognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcomeJ Hepatol201461487688224842305
   PubMed Web of Science ®Google Scholar
• YamashikiNSugawaraYTamuraSLiving-donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndromeHepatol Res201242101016102322548727
   PubMed Web of Science ®Google Scholar
• DemetrisAJAdeyiOBellamyCOBanff Working Group Liver biopsy interpretation for causes of late liver allograft dysfunctionHepatology200644248950116871565
   PubMed Web of Science ®Google Scholar
• XuYTLiuDJMengFYLiGBLiuJPossible benefit of splenectomy in liver transplantation for autoimmune hepatitisHepatobiliary Pancreat Dis Int201413332833124919618
   PubMed Web of Science ®Google Scholar
• MaruokaRAokiNKidoMSplenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitisGastroenterology20131451209.e220.e23523671
   PubMed Web of Science ®Google Scholar
• LapierrePBélandKYangRAlvarezFAdoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral toleranceHepatology201357121722722911361
   PubMed Web of Science ®Google Scholar